IgG subclass deficiency.

J L Preud'homme; L A Hanson

Home/Archive/PubMed

PubMed · 2223061

IgG subclass deficiency.

J L Preud'homme·L A Hanson

View original source ↗Export metadata ↓

Abstract

Although the occurrence of selective deficiencies of serum IgG subclasses has been known for 20 years, the large body of data presently available was collected only recently owing to the use of performing monoclonal antibodies. IgG subclass deficiency is frequent, both as an apparently isolated defect (about one fourth of patients suffering otherwise unexplained repeated infections) and in association with a number of primary and required immunodeficiency states. This paper briefly reviews the methodological problems of serum IgG subclass measurement and data on subclass deficiency in a variety of clinical conditions.

Explore related subjects

Acquired Immunodeficiency Syndrome Ataxia Telangiectasia Bone Marrow Transplantation Dysgammaglobulinemia Humans IgG Deficiency Immunoglobulin Isotypes Immunologic Deficiency Syndromes Wiskott-Aldrich Syndrome Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

J L Preud'homme, L A Hanson. 1990. IgG subclass deficiency.. https://pubmed.ncbi.nlm.nih.gov/2223061/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Molecular pathogenesis of AIDS-associated Kaposi's sarcoma: growth and apoptosis.

Explore the source record for details and available documents.

Acquired Immunodeficiency Syndrome↗

PubMed1999

Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.

HIV-1 gene expression relies upon a complex machinery that is primarily controlled by two viral regulatory proteins, Tat and Rev. Rev is involved in regulating post-transcriptional events of HIV-1 gene expression. The Tat protein transactivates transcription from the HIV-1 5' long terminal repeat (LTR) and acts in synergy with specific cellular factors. Recently, it has been shown that one set of these cellular factors is a protein kinase activity termed TAK (Tat-associated kinase), which activates transcription by hyperphosphorylation of the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II. TAK also enhances transcription of HIV-2, together with the retroviral transactivator, Tat-2. The TAK activity appears to be related to the CTD kinase P-TEFb, which stabilizes transcription elongation of many genes and was originally isolated from Drosophila extracts. Both TAK and P-TEFb contain at least two subunits: the cyclin-dependent kinase, CDK9 (PITALRE), the catalytic subunit, and the regulatory subunit, cyclin T1. CDK9 and cyclin T1 are ubiquitous factors that affects many cellular processes, including cell differentiation and apoptosis. The involvement of TAK in HIV-1 and HIV-2 gene expression is an important aspect in the biology of these two retroviruses, and may lead to the development of novel antiretroviral drugs and/or gene therapy approaches for the treatment of patients with AIDS.

Acquired Immunodeficiency Syndrome↗

PubMed1999

A non-parametric maximum likelihood estimator for bivariate interval censored data.

We derive a non-parametric maximum likelihood estimator for bivariate interval censored data using standard techniques for constrained convex optimization. Our approach extends those taken for univariate interval censored data. We illustrate the estimator with bivariate data from an AIDS study.

Acquired Immunodeficiency Syndrome↗